Dr. Castellarin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E Micheltorena St
Ste A
Santa Barbara, CA 93103Phone+1 805-963-1648Fax+1 805-965-5214
Education & Training
- Rutgers New Jersey Medical SchoolResidency, Ophthalmology, 1999 - 2002
- Rutgers Health/St Barnabas Medical CenterResidency, Surgery, 1998 - 1999
- OtherClass of 1990
Certifications & Licensure
- CA State Medical License 2004 - 2025
- GA State Medical License 2002 - 2011
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Analysis of Aqueous and Vitreous Humor Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- 29 citationsPlasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.Lee M. Jampol, Adam R. Glassman, Danni Liu, Lloyd Paul Aiello, Neil M. Bressler
Ophthalmology. 2018-03-07 - 213 citationsSystemic Pharmacokinetics And Pharmacodynamics Of Intravitreal Aflibercept, Bevacizumab, And RanibizumabRobert L. Avery, Alessandro A. Castellarin, Nathan C. Steinle, Dilsher S. Dhoot, Dante J. Pieramici
Retina. 2017-10-01 - 112 citationsChange in diabetic retinopathy through 2 years secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumabSusan B. Bressler, Danni Liu, Adam R. Glassman, Barbara A Blodi, Alessandro A. Castellarin
JAMA Ophthalmology. 2017-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: